secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0000950170-24-050569
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours Q1 earnings: net sales $1.35B (-12% YoY), net income $52M, adj EBITDA $193M
--------------------------------------------------------------------------------

- Net sales $1.35B, down 12% YoY; volumes -6%, price -5%.
- Net income attributable to Chemours $52M ($0.34 per diluted share) vs $145M ($0.96) in Q1 2023.
- Adjusted EBITDA $193M vs $304M (-37%).
- Cash flows used in operations -$290M; capex $102M; dividends $37M.
- Segment declines: APM -23%, TT -7%, TSS -8%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/0000950170-24-050569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/cc-20240430.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-050569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer